Connect cardiac electrophysiology and rhythm assessment with antiarrhythmic drug mechanisms, clinical selection, monitoring, and prevention of proarrhythmic harm.
Course Content
01. Why Antiarrhythmic Drugs Are High-Risk Drugs
You don't currently have access to this content
02. Normal Cardiac Conduction
You don't currently have access to this content
03. ECG Intervals: What Drugs Change
You don't currently have access to this content
04. Ventricular Action Potential and Ion Currents
You don't currently have access to this content
05. Nodal Action Potential and Autonomic Control
You don't currently have access to this content
06. Mechanisms of Arrhythmogenesis
You don't currently have access to this content
07. First Clinical Decision: Stable or Unstable?
You don't currently have access to this content
08. Vaughan Williams Classification
You don't currently have access to this content
09. Class I Shared Biophysics
You don't currently have access to this content
10. Class I Subgroups: Kinetics and ECG Effects
You don't currently have access to this content
11. Class IA: Quinidine, Procainamide, Disopyramide
You don't currently have access to this content
12. Class IB: Lidocaine and Mexiletine
You don't currently have access to this content
13. Class IC: Flecainide, Propafenone, and CAST
You don't currently have access to this content
14. Class II: Beta Blockers
You don't currently have access to this content
15. Class IV: Non-DHP Calcium Channel Blockers
You don't currently have access to this content
16. Adenosine: The AV Node Reset Drug
You don't currently have access to this content
17. Class III: Potassium Channel Blockers
You don't currently have access to this content
18. Reverse Use-Dependence
You don't currently have access to this content
19. Amiodarone: Broad-Spectrum Multi-Channel Drug
You don't currently have access to this content
20. Amiodarone Toxicity and Monitoring
You don't currently have access to this content
21. Other Class III and Amiodarone-Related Drugs
You don't currently have access to this content
22. Magnesium, Electrolytes, and Torsades
You don't currently have access to this content
23. Digoxin: AV Nodal Drug and Toxicity Trap
You don't currently have access to this content
24. Bradyarrhythmia Pharmacology
You don't currently have access to this content
25. Atrial Fibrillation and Flutter: Framework
You don't currently have access to this content
26. WPW and Pre-Excited Atrial Fibrillation
You don't currently have access to this content
27. PSVT: AV Node-Dependent Tachycardia
You don't currently have access to this content
28. Wide-Complex Tachycardia and Ventricular Tachycardia
You don't currently have access to this content
29. Comparative Safety Matrix
You don't currently have access to this content
30. Final Board-Ready Drug Selection Map
You don't currently have access to this content